MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a special diet and a step counter slow down early blood cancer?
Disease control Not yet recruitingThis small pilot study will test whether a Korean-style Mediterranean diet (KORMED) combined with daily step tracking is practical and beneficial for 20 adults with MGUS or smoldering myeloma, which are early, often pre-cancerous blood conditions. Participants will follow the die…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC